Bixiye
QP34-21 Is Authorization Required (IAR) Tool for Outpatient Authorization on Availity Portal
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Natiijooyinka Raadinta
Soo bandhiga 1671 - 1680 ee natiijooyinka 4229
Bixiye
QP36-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: ZokinvyTM (lonafarnib) PA with QL
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP35-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Verquvo® (vericiguat) PA with QL
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP38-21 Commercial and MHCP Pharmacy Benefit Exclusion for Abecma®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP33-21 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) Criteria: Winlevi®
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2021
Bixiye
QP25-21 Reminders Related to the Submission of Prior Authorizations and Subsequent Claims
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP32-21 Reminder: New Claim Edits For Professional Lab Claims Missing Required Data
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP27-21 MHCP Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP24-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021